Evidence map›Paper›PMID 29191928›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2018

Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice.

Vijaya Karoor, Mehdi A Fini, Zoe Loomis, Timothy Sullivan, Louis B Hersh, Evgenia Gerasimovskaya, David Irwin, Edward C Dempsey

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Extreme Diversity of the Human Vascular Mesenchymal Cell Landscape.Journal of the American Heart Association · 2020
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Annual Report on Sex in Preclinical Studies:Arteriosclerosis, thrombosis, and vascular biology · 2020
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Vijaya KaroorFrom the Cardiovascular Pulmonary Research Laboratory (V.K., M.A.F., Z.L., T.S., E.G., D.I., E.C.D.) and Division of Pulmonary Sciences and Critical Care Medicine (V.K., M.A.F., E.C.D.), University of Colorado Anschutz Medical Campus, Aurora; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington (L.B.H.); and Pulmonary and Critical Care, Denver VA Medical Center, CO (E.C.D.). vijaya.karoor@ucdenver.edu.
Mehdi A FiniFrom the Cardiovascular Pulmonary Research Laboratory (V.K., M.A.F., Z.L., T.S., E.G., D.I., E.C.D.) and Division of Pulmonary Sciences and Critical Care Medicine (V.K., M.A.F., E.C.D.), University of Colorado Anschutz Medical Campus, Aurora; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington (L.B.H.); and Pulmonary and Critical Care, Denver VA Medical Center, CO (E.C.D.).
Zoe LoomisFrom the Cardiovascular Pulmonary Research Laboratory (V.K., M.A.F., Z.L., T.S., E.G., D.I., E.C.D.) and Division of Pulmonary Sciences and Critical Care Medicine (V.K., M.A.F., E.C.D.), University of Colorado Anschutz Medical Campus, Aurora; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington (L.B.H.); and Pulmonary and Critical Care, Denver VA Medical Center, CO (E.C.D.).
Timothy SullivanFrom the Cardiovascular Pulmonary Research Laboratory (V.K., M.A.F., Z.L., T.S., E.G., D.I., E.C.D.) and Division of Pulmonary Sciences and Critical Care Medicine (V.K., M.A.F., E.C.D.), University of Colorado Anschutz Medical Campus, Aurora; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington (L.B.H.); and Pulmonary and Critical Care, Denver VA Medical Center, CO (E.C.D.).
Louis B HershFrom the Cardiovascular Pulmonary Research Laboratory (V.K., M.A.F., Z.L., T.S., E.G., D.I., E.C.D.) and Division of Pulmonary Sciences and Critical Care Medicine (V.K., M.A.F., E.C.D.), University of Colorado Anschutz Medical Campus, Aurora; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington (L.B.H.); and Pulmonary and Critical Care, Denver VA Medical Center, CO (E.C.D.).
Evgenia GerasimovskayaFrom the Cardiovascular Pulmonary Research Laboratory (V.K., M.A.F., Z.L., T.S., E.G., D.I., E.C.D.) and Division of Pulmonary Sciences and Critical Care Medicine (V.K., M.A.F., E.C.D.), University of Colorado Anschutz Medical Campus, Aurora; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington (L.B.H.); and Pulmonary and Critical Care, Denver VA Medical Center, CO (E.C.D.).
David IrwinFrom the Cardiovascular Pulmonary Research Laboratory (V.K., M.A.F., Z.L., T.S., E.G., D.I., E.C.D.) and Division of Pulmonary Sciences and Critical Care Medicine (V.K., M.A.F., E.C.D.), University of Colorado Anschutz Medical Campus, Aurora; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington (L.B.H.); and Pulmonary and Critical Care, Denver VA Medical Center, CO (E.C.D.).
Edward C DempseyFrom the Cardiovascular Pulmonary Research Laboratory (V.K., M.A.F., Z.L., T.S., E.G., D.I., E.C.D.) and Division of Pulmonary Sciences and Critical Care Medicine (V.K., M.A.F., E.C.D.), University of Colorado Anschutz Medical Campus, Aurora; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington (L.B.H.); and Pulmonary and Critical Care, Denver VA Medical Center, CO (E.C.D.).
University of Kentucky · US

Funding

VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
Extracellular ATP: potential regulator of hypoxia-induced vasa vasorum neovasculaR01HL086783 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GERASIMOVSKAYA, EVGENIA V · 2008 to 2017
$4.2M
The contribution of free hemoglobin in the progression of pulmonary remodelingR01HL125642 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI IRWIN, DAVID CHARLES · 2015 to 2019
$1.9M
Neprilysin Apoptosis and Hypoxic Pulmonary HypertensionR01HL078927 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DEMPSEY, EDWARD CHARLES · 2005 to 2008
$1.5M
Selected Peptidases and Pulmonary Vascular Remodeling in Chronic Obstructive PulmR03HL095439 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DEMPSEY, EDWARD CHARLES · 2008 to 2009
$154k
NHLBI NIH HHS P01 HL014985NHLBI NIH HHS R01 HL078927NHLBI NIH HHS R01 HL086783NHLBI NIH HHS R01 HL125642NHLBI NIH HHS R03 HL095439NHLBI NIH HHS T32 HL007171
6 · The paper itself

Abstract

objectivePulmonary artery smooth muscle cells (PASMCs) from neprilysin (NEP) null mice exhibit a synthetic phenotype and increased activation of Rho GTPases compared with their wild-type counterparts. Although Rho GTPases are known to promote a contractile SMC phenotype, we hypothesize that their sustained activity decreases SM-protein expression in these cells. APPROACH AND

resultsPASMCs isolated from wild-type and NEP

conclusionsSustained Rho activation in NEP

Indexed as

ActinsAnimalsBecaplerminCalcium-Binding ProteinsCalponinsCell MovementCell ProliferationCells, CulturedEndothelin-1Enzyme Activationets-Domain Protein Elk-1GenotypeHumansKruppel-Like Factor 4Kruppel-Like Transcription FactorsMice, Inbred C57BLActinsalpha-smooth muscle actin, mouseBecaplerminCalcium-Binding ProteinsCalponinsElk1 protein, mouseEndothelin-1ets-Domain Protein Elk-1KLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription FactorsMicrofilament ProteinsMuscle ProteinsNeprilysinrho GTP-Binding ProteinsSmooth Muscle Myosinscalponinneprilysinphenotypephosphorylationpulmonary artery

Identifiers

PMID29191928
PMCPMC5746466
OpenAlexW2775303211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.